STOCK TITAN

IRIDEX (IRIX) CFO adds 6,668 shares in open-market buys

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased shares of the company’s Common Stock. On 2026-08-24, he bought 1,300 shares at $0.7488 per share and 5,368 shares at $0.7499 per share in open-market or private transactions. Following these purchases, his reported direct ownership increased to 169,952 Common Stock shares.

Positive

  • None.

Negative

  • None.
Insider Dizon Romeo R
Role Chief Financial Officer
Bought 6,668 shs ($5K)
Type Security Shares Price Value
Purchase Common Stock 1,300 $0.7488 $973.44
Purchase Commn Stock 5,368 $0.7499 $4K
Holdings After Transaction: Common Stock — 164,584 shares (Direct); Commn Stock — 169,952 shares (Direct)
Shares purchased (first transaction) 1,300 shares Common Stock purchased on 2026-08-24 at $0.7488 per share
Price per share (first transaction) $0.7488 per share Purchase of 1,300 Common Stock shares on 2026-08-24
Shares purchased (second transaction) 5,368 shares Common Stock purchased on 2026-08-24 at $0.7499 per share
Price per share (second transaction) $0.7499 per share Purchase of 5,368 Common Stock shares on 2026-08-24
Total shares purchased 6,668 shares Sum of two Common Stock purchase transactions on 2026-08-24
Shares owned after transactions 169,952 shares Direct Common Stock ownership of CFO Romeo R. Dizon following reported purchases
Form 4 regulatory
"What insider transactions did IRIX report for CFO Romeo R. Dizon on this Form 4?"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Rule 10b5-1 regulatory
"The document-level Rule 10b5-1 checkbox is unchecked (aff_10b5_one is false)"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Common Stock financial
"purchased a total of 6,668 shares of IRIDEX CORP Common Stock on 2026-08-24"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open market or private transaction market
"in two open-market or private purchase transactions"
non-derivative financial
"transaction_type non-derivative for the reported Common Stock purchases"

FAQ

What insider transactions did IRIX report for CFO Romeo R. Dizon on this Form 4?

The filing reports that CFO Romeo R. Dizon purchased a total of 6,668 shares of IRIDEX CORP Common Stock on 2026-08-24 in two open-market or private purchase transactions.

At what prices did the IRIX CFO buy shares in this Form 4 filing?

Romeo R. Dizon purchased 1,300 shares at $0.7488 per share and 5,368 shares at $0.7499 per share of IRIDEX CORP Common Stock.

How many IRIX shares does the CFO own after these reported purchases?

After the reported transactions, CFO Romeo R. Dizon’s direct ownership in IRIDEX CORP Common Stock is 169,952 shares, according to the Form 4 data.

Were the IRIX insider purchases made under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is unchecked (aff_10b5_one is false), indicating the reported transactions were not affirmed as being made under a Rule 10b5-1 trading plan.

Does this IRIX Form 4 report any stock sales by the CFO?

No. The Form 4 data show two purchase transactions (code P) totaling 6,668 shares and no reported sales or other dispositions by CFO Romeo R. Dizon in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dizon Romeo R

(Last)(First)(Middle)
1212 TERRA BELLA AVENUE

(Street)
MOUNTAIN VIEW CALIFORNIA 94043

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/24/2026P1,300A$0.7488164,584D
Commn Stock08/24/2026P5,368A$0.7499169,952D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)